Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_assertion description "[The mitochondrial outer membrane protein mitoNEET is a binding protein of the insulin sensitizer pioglitazone (5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione) and is considered a novel target for the treatment of type II diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_assertion evidence source_evidence_literature NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_assertion SIO_000772 25503385 NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_assertion wasDerivedFrom befree-2016 NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_assertion wasGeneratedBy ECO_0000203 NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1247893.RAuNfGPxEKJ3wYEC4R5zqmQi0_mTR61mUiT7fuI8Bw5yE130_provenance.